rhEndostatin Protein Involving Pediatric Patients With Cancer
Clinical trial NCT00165373 · TERMINATED
Trial details
- NCT number
- NCT00165373
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2005-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.